ReviewCureus2025

Evidence From a Systematic Review of Non-alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Fueling Cardiovascular Risk.

Nehal K Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.